Literature DB >> 3814469

DNA flow cytometric study of 5-fluorouracil used to treat end stage non-Hodgkin's lymphoma.

D W Hedley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3814469      PMCID： PMC2001581          DOI： 10.1038/bjc.1987.22

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Five years clinical experience with 5-fluorouracil.

Authors:  F J ANSFIELD; J M SCHROEDER; A R CURRERI
Journal:  JAMA       Date:  1962-07-28       Impact factor: 56.272

2.  Use of 5-fluorouracil in the management of advanced maligancies in childhood.

Authors:  W KRIVIT; H P BENTLEY
Journal:  Am J Dis Child       Date:  1960-08

3.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

4.  Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.

Authors:  J R Bertino; W L Sawicki; C A Lindquist; V S Gupta
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

5.  Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis.

Authors:  L L Vindeløv; H H Hansen; A Gersel; F R Hirsch; N I Nissen
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

6.  Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck.

Authors:  J A Kish; A Weaver; J Jacobs; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

7.  Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; L Vindeløv; A Nielsen
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.